On July 8, BGI announced in Beijing that it would launch the “10 million families away from genetic birth defects” program. The program has launched a series of "technical public welfare" projects for rare diseases, including the "Ziqi Plan" for patients with mucopolysaccharidosis, the "Spring Uncle Plan" for thalassemia and the "Xiaoming Plan" for ichthyosis.